Studies

We are looking for individuals 18 years and older who suffer from moderate to severe acne get subjects will get compensated for your time and travel. All subjects must have current visible active acne.

Eligible Participants Are

• Individuals with moderate to severe acne (minimum of 3 lesions, including at least 1 inflammatory lesion)
• Healthy males and females, aged 18-45
• Able to follow study procedures and sign informed consent
• Willing to be photographed and sign a consent release

The PILLAR Study is only for people who, experienced at least one exacerbation at least in the last 12 months, who has been prescribed COPD maintenance triple therapy (a combination of an anti-inflammatory inhaled medication and two inhaled bronchodilators).

Eligible Participants Are

• Be at least 40 years of age
• Have COPD and chronic bronchitis with current symptoms
• Be a current or former smoker who quit 6 or more months before entering the study
• Have had at least one documented COPD exacerbation in the past 12 months

Asthma is a common chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to recurrent episodes of wheezing, coughing, shortness of breath, and chest tightness.

Eligible Participants Are

• Must be at least 18 years old
• Have had asthma diagnosed for at least one year prior to participating in the study
• At least one documented asthma exacerbation within the past 12 months

If you’re exploring potential treatment options for you skin medical condition, we invite you to learn more about our Vitiligo clinical trial.

Eligible Participants Are

• Must be at least 18 years of age
• Diagnosed with nonsegmental vitiligo for at least 3 months
• Have vitiligo on both the face and body
• Vitiligo can be either active or stable